Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

Clinical trial NCT05281614 · COMPLETED

Trial details

NCT number: NCT05281614
Sponsor: Benaroya Research Institute
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2022-09-21
Primary completion: 2024-01-10
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.